MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.pmedr.2021.101650

Медицинская библиотека · Preventive medicine reports · 2021

Smokeless Tobacco Use and Prevalence of Cardiovascular Disease Among Males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1-4.

Nahhas Georges J, Cummings K Michael, Halenar Michael J, Sharma Eva, Alberg Anthony J, Hatuskami Dorothy, Bansal-Travers Maansi, Hyland Andrew, Gaalema Diann E, Morris Pamela B, Duffy Kara, Chang Joanne T, Lagaud Guy, Vivar Juan C, Marshall Daniela, Blanco Carlos, Taylor Kristie A

СтатьяПеревод в очереди

Аннотация

The purpose of this period prevalence study is to compare the prevalence of cardiovascular disease (CVD) in current/former established smokeless tobacco (SLT) users (ever SLT users who have used the product fairly regularly) to those who were: 1) never established cigarette smokers and SLT users, and 2) current/former established exclusive cigarette smokers (have smoked at least a 100 or more cigarettes in lifetime) only, adjusting for known risk factors for CVD. Analyses included 4,703 men ≥ 40 years of age who participated in the Population Assessment of Tobacco and Health (PATH) Study, Waves: 1-4, conducted between 2013 and 2017. Current users were those using SLT products daily or on some days, whereas former users had not used SLT and/or cigarettes in the past 12 months. CVD prevalence was defined as a self-reported diagnosis of congestive heart failure, stroke, or myocardial infarction. Among current/former established SLT users, years of use defined exposure history, while pack-years defined exposure history for smokers. Adjusted odds ratios (AOR) and 95% confidence intervals (CI) were reported with trend tests to examine dose-response associations. Current/former established exclusive SLT users were not significantly more likely to have had any CVD compared to never established cigarette and SLT users (OR = 1.7 [0.8-3.7]), or current/former established exclusive cigarette smokers (OR = 0.9 [0.5-1.8]). Current/former established exclusive cigarette smokers were more likely to have had any CVD compared to those who were never established cigarette and SLT users (OR = 1.6 [1.1-2.3]).

Для цитирования: Nahhas Georges J, Cummings K Michael, Halenar Michael J, Sharma Eva, Alberg Anthony J, Hatuskami Dorothy, Bansal-Travers Maansi, Hyland Andrew, Gaalema Diann E, Morris Pamela B, Duffy Kara, Chang Joanne T, Lagaud Guy, Vivar Juan C, Marshall Daniela, Blanco Carlos, Taylor Kristie A. Smokeless Tobacco Use and Prevalence of Cardiovascular Disease Among Males in the Population Assessment of Tobacco and Health (PATH) Study, Waves 1-4.. Preventive medicine reports. 2021. DOI: 10.1016/j.pmedr.2021.101650.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.